A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Regorafenib (Stivarga, BAY73-4506) Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Learning | Research | Study | Universities & Medical Training